Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001000275-26-000034
Filing Date
2026-03-20
Accepted
2026-03-20 12:56:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2778
  Complete submission text file 0001000275-26-000034.txt   4229
Mailing Address C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011
Business Address
WAGENHEIM PHILIP (Reporting) CIK: 0001405684 (see all company filings)

Type: 144

Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Subject) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39580 | Film No.: 26777364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)